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Feeding the Future Meat Doesn’t Come Cheap
It’s one of the last hot days in September. At a nondescript hotel down the road from the
Pentagon, the two-day Reducetarian Summit has gathered people from the alternative protein
industry. It’s a chance for people interested in creating a worldwide, sustainable food system to
discuss innovation. Everyone is talking about plant-based meat companies like Beyond Meats
and Impossible Foods, but Lou Cooperhouse is here to sell people on something even more
groundbreaking.
His company, BlueNalu, is using cellular agriculture technology to develop lab-grown seafood.
Cellular agriculture – cell-ag for short – is the scientific process that uses tissue engineering
technology to grow muscle or fat from cell cultures in a laboratory. Unlike plant-based proteins,
the cultured meat or seafood that BlueNalu and nearly 50 other food-tech startups are researching
is genetically the same as animal or fish protein.
“We’re making a fish product from fish cells. It is fish from fish,” he says.
Biologically the fish meat they are growing will look, taste and feel no different than a fillet that
came from a once-swimming fish. The difference is that the product was never a living fish, can
be made in a landlocked location, will be free of mercury and, most importantly, will not require
the labor, energy, pollution and death that come with traditional fishing.
“We’re importing 94% of our seafood. We’re dealing with issues like microplastics and toxins
and potential nuclear fallout. So, hello? It’s time to do something,” he says with the matter-offact tone of someone who has used this argument before. “We’re just not gonna have enough
fish.”
Cooperhouse leans back in his chair comfortably. He is wearing two pins on his conference
lanyard: one reads “West Coaster” and the other reads “East Coaster,” which aptly describes the
businessman who seems to be crisscrossing the world speaking at nearly every food-tech
conference. He is selling both his company and the idea of cellular agriculture as the answer to
world hunger – in his case, by growing seafood in production facilities.
Plant-based meat companies like Impossible Foods and Beyond Meat have already proven that
there is a market and consumer interest in alternative proteins outside of the niche vegan and
vegetarian communities. Cell-ag technology serves the same purpose, providing a sustainable
protein source without the problems of conventional agriculture. Cultured seafood and meat
companies say that true meat-eaters will not be fully satisfied with fake meat made from plants.
Consumers want to eat an exact replica of true animal meat that can’t be differentiated from a
steer’s tenderloin steak or a loin fillet from tuna.
The amount of meat that can be produced using conventional means cannot keep up with a
growing world population. Demand for meat is steadily growing in emerging markets like
Southeast Asia and China. As a result, Singapore has invested $114 million as a country in
cultured meat technology. China has agreed to pay $300 million to three Israeli-based cultured
meat companies for their eventual cultured food products as part of a 2017 trade agreement.

Consulting firm AT Kearney predicts that in 20 years, 60% of global meat consumption will
come from alternative protein sources, between plant-based and cell-ag products. Currently, the
meat market is estimated to be worth over $1.4 trillion dollars globally and growing about 2%
every year.
Big meat and food companies are taking notice of the problems with the current way they
produce and distribute meat. Cargill and Tyson Foods have both invested in cell-ag company
Memphis Meats which raised $17 million in a Series A funding. Tyson has also put money into
Israeli company Future Foods. Big pharmaceutical company Merck and European poultry giant
PHW have been slowly investing in key areas of the industry as well.
Cell ag may have the potential to solve world hunger, food deserts, land-use and environmental
degradation. But first, innovation is needed to scale up production to meet the needs of retail
distribution. Cultured food startups also need significant funding to continue their trajectory
toward full-scale production. Finally, the U.S. Department of Agriculture and the Food and Drug
Administration will have to agree on the regulation of how the final product can be labelled and
marketed to reach consumers.
Scaling is the first hurdle.
“We’re talking about a wide array of people, with different labs who don’t know what each other
are doing. To us, it’s a black-box,” said Ben Wurgraft, author of “Meat Planet: Artificial Flesh
and the Future of Food.”
He spent over four years researching the technology and the implications of this growing
industry and concluded that the secrecy that dominates the industry is slowing innovation. “The
thing that is unknowable at the moment is whether or not the major technical hurdles to creating
relatively memetic, lab-grown meat in vegan-compatible fashion has been overcome,” he said.
Bioreactors that can provide the optimal environment to replicate and grow the animal cells –
which form the building blocks for a cultured piece of meat or fish – are the key. At the moment,
almost all bioreactors are too small for large-scale production. Also, there isn’t a consensus on
the most efficient type of bioreactor to use. The most promising approach may be following in
the footsteps of microbreweries. Their huge stainless-steel tanks are the model for new bioreactor
designs. Some could even be repurposed for cell-ag production. Lou Cooperhouse even prefers
the term “brewed meat” to cultured.
Israeli cultured meat company Future Foods might be the first to build a working production
facility. They recently announced a $14 million investment that will go towards making the
world’s first cultured meat factory.
In addition to bioreactors, cells need to be fed in order to replicate. The “food” is called a growth
media. Initially, the most effective media was Fetal Bovine Serum – or FBS. The serum comes
from unborn calves removed from pregnant steers during animal processing in slaughterhouses.

It is a counter-intuitive media to use for a product that claims to be cruelty-free or slaughter-free.
Also, FBS is expensive and the efficacy can be highly variable from batch-to-batch.
Now most cultured meat companies have developed plant-based alternatives to the growth
media, but maintaining the same efficiency as FBS and producing it inexpensively are the key.
This is one major area of intellectual property that companies are guarding. In order to produce
cultured meat to scale quickly and inexpensively, an efficient animal-free growth media is
necessary.
Companies like Multus Media and Heuros specialize solely in developing inexpensive, animalfree growth mediums.
For the cells to grow efficiently, they need a surface to grow. More importantly, for the industry
to compete with conventional meat, it needs to produce recognizable cuts of meat like steaks,
chops, and loins. Presently, cultured products are a mush of meat that can be made into burgers,
sausages, nuggets, or fish cakes.
This is where scaffolding comes in. It would not only help companies make that slaughter-free
ribeye that a steak lover could sink his or her teeth into, but it is actually necessary to the process
of growing longer cell strands that will give cultured meat the proper texture.
There has been some innovation in scaffolding. Some research is being done with cyanobacteria
or even fungi cells.
Companies using 3-D printing technology to create plant-based meat alternatives are now
adapting their machines to build cuts of cultured meat. They are making animal muscles in a lab,
but for a different purpose than nature intended.
“You don’t want to build a muscle that works like a muscle,” explained Guiseppe Scionti,
founder and CEO of Barcelona-based 3-D meat printing company NovaMeat. “You can build a
simplification. A muscle that tastes, has a texture, the appearance and the nutritional properties
of a muscle.”
To achieve scale, companies need money and, at the moment, that is scarce. Big food companies
have made key investments, but Tyson and Cargill haven’t started cell-ag departments with the
full weight of their resources behind innovation. Eventually, these companies are expected to
jump headfirst into the industry but only once the technological obstacles are solved.
“It’s far more likely that the biggest purveyors of clean meat will be the Tysons and Cargills and
JBSs of the world,” said Paul Shapiro, author of the book “Clean Meat: How Growing Meat
Without Animals Will Revolutionize Dinner and the World.” “Nobody knows how to sell meat
like they do. Nobody has the distribution channels, the meat science background, the expertise,
the production and processing plants.”
For example, Impossible Burger was forced to enlist the help of a larger food corporation – OSI
Group – to efficiently keep up with production needed to supply Burger King.

In the meantime, raising money is a problem. The Good Food Institute (or GFI) – the most
prominent non-profit, advocacy group for the alternative protein industry – estimated there were
27 cultured meat companies by the end of 2018, a figure that has increased to about 50 cultured
food companies worldwide. Most of these are in very early stages of startup investment;
primarily, seed or Series A funding.
A lot of resources are devoted to courting the investment of just a few small, “conscious-capital”
venture funds – VC funds who invest in sustainable food companies that focus on humane
animal practices. Stray Dog Capital, New Crop Capital and the Glasswall Syndicate are leading
the charge with both plant-based and cultured meat investments.
“You can solve food desert issues, world-wide starvation issues if the funding is there to make
this happen wherever it needs to happen,” says Curt Albright, the founder and sole manager of
the Clear Current Capital, a smaller VC fund.
Clear Current is focused on investment in plant-based meat companies, but they have made one
key investment with Lou Cooperhouse’s BlueNalu because of the company’s realistic business
plan. Assuming the technological hurdles are solved, cultured meat has the potential to make a
bigger ecological impact than even a plant-based model due to the ability to produce protein with
even less resources, Albright said.
This is where the conscious part of conscious capital investing comes from. These VC funds are
addressing a problem in our food system and although the end game is to make a profit, the point
is not purely financial.
“We address center-of-the-plate animal agriculture issues. It’s incredibly inefficient to feed
nutrients to animals and then slaughter the animals and then eat the animals,” said Mark Langley
of the New Crop Capital, another major VC fund for alternative proteins.
Both Albright and Langley insist that conscious capital investment doesn’t yield to the traditional
VC search for profitability. Cultured companies must be moving towards profitability, but the
timetable is more flexible than other VC funds.
The cultured sector remains small – an estimated $50 to $74 million invested in comparison to
the estimated $900 million invested in plant-based alternatives.
Yet, not all investment is based on a return. The non-profit New Harvest was established in 2004
as the first research organization solely devoted to cell-ag and its application for innovating food
systems. The organization provides grants to researchers working on cell-ag in academia.
New Harvest advocates for an open-source model for cell-ag research. The group says that an
academic framework provides transparency, which will in turn ease government regulation and
customer approval of the product.

“This is a new industry that is not yet bound up in this huge tangle of government subsidies and
lobbyists and meat companies,” said Meera Zassenhaus, engagement associate for New Harvest.
“It’s a way to start fresh with the food system and I would be personally disappointed if it just
recreates and reproduces our existing livestock to food-animal production.”
Her office is in a nondescript building in downtown Brooklyn. The building’s door is littered
with Post-It notes directing deliveries and guests to ring certain numbers. The upstairs office is
dark with assorted bulletin and white boards brainstorming the organization’s strategy and grant
proposals.
New Harvest was an early sponsor of the cultured dairy company Perfect Day, an early example
of the marketability of a cultured food product. Perfect Day uses cell-ag technology to
genetically-modify dairy cells to create cultured ice cream. The first batch of the product sold out
on their website within hours. Recently, the company completed a new round of funding to
increase production and make partnerships with food distributors.
Perfect Day was able to sell their cultured dairy product before any cultured meat or seafood
products because USDA regulations for dairy – even cultured dairy – are far less stringent than
the oversight of the meat and seafood industry. In general, there is still very little information
about how the government plans to regulate meat and seafood using cell-ag technology.
What is known is that the FDA and the USDA will be co-regulating the industry. The FDA will
oversee all things on the backend involving the cells – collection, growth, differentiation and cell
banks. After the cells are harvested, the Food Safety and Inspection Service (FSIS) of the USDA
will take over the regulatory oversight of production and labeling of food products. No other
specifics have been given at this point; most especially, how the labelling of cultured products
will be regulated.
Food labelling has become fertile ground for the first pitched battle between conventional meat
companies and the alternative meat community. Ranchers and cattlemen have seen a dip in
profits as a result of the interest in plant-based meats. The eventual rise of cultured meat will
only dip further into the traditional meat industry’s market share. Conventional meat producers
are going after the alternative protein and cell-ag industry by trying to restrict what can or cannot
be labelled “meat.” Yet, this is not a fight for giants like Tyson, Nestlé or Hormel, this is a fight
for the cattlemen, ranchers and even the farmers who are growing feed grain.
Recently, a bipartisan bill with the strained acronym the Real M.E.A.T – Marketing Edibles
Artificially Truthfully – Act was proposed in Congress. Its aim is to forbid the use of the word
meat on the labels of plant-based or cultured meat products. Proponents of these laws say that
plant-based or fake meat foods are deceiving consumers by using descriptors such as meat,
sausage or burger in the product names. Food Dive reports there are “45 different bills on meat
labeling proposed in 26 states as of August.”
“It is critical that food labeling is not deceptive or misleading to enable consumers to make
informed choices about the products they purchase,” said Sarah Little, media representative for
the North American Meat Institute. “As an industry, we support a fair and competitive

marketplace that lets consumers decide what food products make sense for them. Imitation is the
highest form of flattery.”
This year, five of the biggest cultured meat companies created a coalition called the Alliance For
Meat, Poultry And Seafood Innovation (or the AMPS Coalition); comprising of BlueNalu, JUST,
Forke and Goode, Memphis Meats and Finless Foods as the founding members.
AMPS will provide a loose association to lobby for the cultured protein industry while also
providing a framework to combat opposition similar to the food labelling battles already being
fought.
The challenges facing cultured protein are huge but so is the potential. Not only does cell-ag
address a lot of the environmental concerns facing the current food system, but the market
potential is huge and could lead to a boon to alternative proteins profitability.
“It’s an opportunity to make entirely new foods that we never had the ability to do when we were
constrained by the animal’s body,” said Zassenhaus. “The technology is allowing us to make
things that we never could have dreamed of before.”
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